Product Wiki · Recalls · UK OPSS (Office for Product Safety and Standards)

Pilgrim anti dandruff shampoo and conditioner set — product safety report 2510-0132

UK OPSS (Office for Product Safety and Standards) · GB · 2026-01-27 · Product Safety Report

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
UK OPSS (Office for Product Safety and Standards)
Recall identifier
product-safety-report-pilgrim-anti-dandruff-shampoo-and-conditioner-set-sold-via-amazon-2510-0132
Date of alert
2026-01-27
Country / jurisdiction
GB
Authority classification
Product Safety Report
Risk type
product-safety-report
Brand
Pilgrim
Product category
cosmetics
Reported risk: The product presents a serious chemical risk as the ingredients list indicates it contains Zinc Pyrithione, which is prohibited for use in cosmetic products. It also includes the following undeclared allergens: hydroxycitronellal, hexyl cinnamal, and limonene. This could lead to consumers with sensitivities using these products and having an allergic reaction. The product does not meet the requirements of the Regulation (EC) No 1223/2009 on Cosmetic Products.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from UK OPSS (Office for Product Safety and Standards) →

Primary source: https://www.gov.uk/product-safety-alerts-reports-recalls/product-safety-report-p

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.